Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Development of zolmitriptan niosomalin-situ nasal gel

Development of zolmitriptan niosomalin-situ nasal gel

Shinde, Anilkumar
Tamboli, Firoj
Swami, Karan

Paperback

Medical Reference

ISBN10: 6209119247
ISBN13: 9786209119248
Publisher: LAP Lambert Academic Publishing
Published: Oct 27 2025
Pages: 56
Weight: 0.19
Height: 0.13 Width: 6.00 Depth: 9.00
Language: English
The objective of the present investigation was to development of Zolmitriptan (ZMT) niosomal in-situ nasal gel formulation for treatment of migraine. The intranasal route could delivered drug to the central nervous system (CNS) through the olfactory lobes, which helps to circumvent the blood brain barrier (BBB), which bypasses first pass metabolism and consequently enhances the bioavailability of the drug. ZMT niosomes were prepared using lipid film hydration technique. Optimized niosomal formulation was used for preparation of in situ gel formulation. The developed formulations were characterized for vesicle size, shape, zeta potential, entrapment efficiency, drug content and in-vitro diffusion study, mucoadhesive strength, permeation study, FTIR, DSC and XRD studies. The FTIR and DSC studies predicted that there was no chemical interaction between drug and excipients. ZMT niosomes were showed particle size, PDI, Zeta potential, % entrapment efficiency and drug content, 149nm, 0.223, -28.9, 88.16 0.8 % and 96.23 1.2% respectively. In vitro diffusion study of niosomes shows 96.23 0.7% at 8h. The permeation rate of in situ niosomes gel and pure drug was about 98.56% and 79.46%.

Also from

Shinde, Anilkumar

View All

Also in

Medical Reference

View All